OCT seems to reduce periprocedural MI, a benefit not seen in the chronic coronary syndrome patients that deserves further ...

In the ILIAS ANOCA trial, using CFT to guide treatment according to ANOCA endotype led to larger QoL gains over 6 months.

HELSINKI, Finland—It may be possible to safely cut back on the level of monitoring performed in select patients with acute ...

The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...

Researchers used PET/MRI to detect otherwise invisible inflammation. Less clear is how this might influence patient care.

This factor helps explain why the device failed to match other commercially approved devices in the IDE trial.

Citing a low hemorrhage rate and other issues, one expert says the results should be replicated before changing practice.

The TCTMD news team discuss their favorite moments of the month. Today's special guest is Morton Kern.

The free risk calculator can be incorporated into existing spreadsheets of patient data for use in heart team discussions.

A sex gap seen in quality of life deserves further scrutiny, but the DISCHARGE trial data are still reassuring, says Maros ...

The observed treatment rates, which “absolutely can go higher,” wouldn’t be acceptable for serious cancers, Stephen Greene ...

The higher stroke risk appears to accrue over time, and researchers say more work is needed to better understand why.